These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 7455635)

  • 1. Serum sulfhydryl levels in rheumatoid patients treated with haloperidol.
    Grimaldi MG
    Scand J Rheumatol; 1980; 9(4):225-8. PubMed ID: 7455635
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum sulfhydryl levels in rheumatoid patients treated with cyclophosphamide.
    Grimaldi MG
    Scand J Rheumatol; 1980; 9(4):237-40. PubMed ID: 7455636
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term low dose haloperidol treatment in rheumatoid patients: effects on serum sulphydryl levels, technetium index, ESR, and clinical response.
    Grimaldi MG
    Br J Clin Pharmacol; 1981 Oct; 12(4):579-81. PubMed ID: 7295491
    [No Abstract]   [Full Text] [Related]  

  • 4. Long-term low dose ticlopidine treatment in rheumatoid arthritis: effects on serum sulphydryl levels, technetium index, erythrocyte sedimentation rate, and clinical disease activity.
    Grimaldi MG
    Eur J Clin Pharmacol; 1985; 29(2):165-8. PubMed ID: 3000794
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term cyclophosphamide treatment in rheumatoid patients: effects on serum sulphydryl levels, technetium index, ESR and clinical response.
    Grimaldi MG
    Br J Clin Pharmacol; 1981 Oct; 12(4):503-6. PubMed ID: 7295485
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum sulfhydryl levels in rheumatoid patients treated with gold thiomalate and penicillamine.
    Haataja M; Nissilä M; Ruutsalo HM
    Scand J Rheumatol; 1978; 7(4):212-4. PubMed ID: 104378
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum sulphydryl concentrations and antirheumatic drugs in rheumatoid patients.
    Grimaldi MG
    J Pharm Pharmacol; 1980 Dec; 32(12):876. PubMed ID: 6110764
    [No Abstract]   [Full Text] [Related]  

  • 8. [Serum zinc, copper and sulfhydryl groups in osteoarthritis and rheumatoid arthritis].
    Ménard HA; Barrette M; Lamoureux G; St-Pierre C; Lecomte R; Paradis P; Monaro S
    Union Med Can; 1980 Sep; 109(9):1286-8. PubMed ID: 7467006
    [No Abstract]   [Full Text] [Related]  

  • 9. Evaluation of the activity of rheumatoid arthritis. A comparative study on clinical symptoms and laboratory tests with special reference to serum sulfhydryl groups.
    Haataja M
    Scand J Rheumatol Suppl; 1975; 7():1-54. PubMed ID: 1056099
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum copper and erythrocyte superoxide dismutase in rheumatoid arthritis.
    Banford JC; Brown DH; Hazelton RA; McNeil CJ; Sturrock RD; Smith WE
    Ann Rheum Dis; 1982 Oct; 41(5):458-62. PubMed ID: 7125714
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of a single massive intravenous dose of hydrocortisone in rheumatoid arthritis.
    Haataja M; Kalliomaki JL
    Curr Ther Res Clin Exp; 1975 Jan; 17(1):80-7. PubMed ID: 806432
    [No Abstract]   [Full Text] [Related]  

  • 12. Serum sulfhydryl groups in rheumatoid arthritis.
    Haataja M; Kalliomäki JL
    Z Rheumatol; 1977; 36(3-4):73-6. PubMed ID: 871070
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Infliximab equivalently suppresses oxidative stress compared to tocilizumab among well-controlled patients with rheumatoid arthritis.
    Kizaki K; Yamashita F; Hayashi T; Funakoshi N
    Int J Rheum Dis; 2018 Oct; 21(10):1815-1821. PubMed ID: 27778459
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum antioxidant activity and related variables in rheumatoid arthritis. Behaviour during sulphydrylant treatment.
    Ambanelli U; Spisni A; Ferraccioli GF
    Scand J Rheumatol; 1982; 11(4):203-7. PubMed ID: 7178856
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcome of rheumatoid arthritis following adjunct statin therapy.
    Das S; Mohanty M; Padhan P
    Indian J Pharmacol; 2015; 47(6):605-9. PubMed ID: 26729950
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Niclosamide as an adjuvant to etanercept in treatment patients with active rheumatoid arthritis: an 8-week randomized controlled pilot study.
    Al-Gareeb AIA; Gorial FI; Mahmood AS
    Clin Rheumatol; 2018 Oct; 37(10):2633-2641. PubMed ID: 29882203
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A biochemical comparison of alclofenac and D-penicillamine in rheumatoid arthritis.
    Bird HA; Dixon JS; Pickup ME; Lee MR; Wright V
    Ann Rheum Dis; 1980 Jun; 39(3):281-4. PubMed ID: 6106453
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A clinical and biochemical evaluation of etretinate in rheumatoid arthritis.
    Bird HA; Hill J; Sitton NG; Dixon JS; Wright V
    Rheumatol Int; 1988; 8(2):55-9. PubMed ID: 3041545
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ramipril and haloperidol as promising approaches in managing rheumatoid arthritis in rats.
    Fahmy Wahba MG; Shehata Messiha BA; Abo-Saif AA
    Eur J Pharmacol; 2015 Oct; 765():307-15. PubMed ID: 26302059
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between neutrophil-lymphocyte, platelet-lymphocyte ratio and disease activity in rheumatoid arthritis treated with rituximab.
    Sargin G; Senturk T; Yavasoglu I; Kose R
    Int J Rheum Dis; 2018 Dec; 21(12):2122-2127. PubMed ID: 30338636
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.